Devices › Device types
FDA product code MTA · class 3 · Unknown
Lens, intraocular, phakic: medical device reports filed with FDA
22,089 reports carry this product code, 2005–2026; 11 brands with a page.
- 22,089
- reports with this product code
- 0.1% of all MAUDE reports
- 821
- reports, 12 months to August 2026
- 1,098 in the 12 months before
- 19.2%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code MTA is FDA's classification for "Lens, intraocular, phakic" (unknown panel), a class 3 device. 22,089 medical device reports carry this product code, 0.1% of the MAUDE database, from December 2005 to August 2026.
821 reports arrived in the 12 months to August 2026, down 25% from 1,098 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (80.4%), malfunction (19.2%) and other (0.3%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Implantable Collamer Lens Icl | 13,396 | 41 | 0% | 19.9% |
| Icl Implantable Collamer Lens | 4,477 | 0 | 0% | 9.6% |
| Visian ICL (Implantable Collamer Lens) | 2,314 | 10 | 0% | 24.9% |
| Implantable Collamer Lens | 599 | 1 | 0.1% | 42.4% |
| EVO/EVO+VISIAN Implantable Collamer Lens | 419 | 978 | 0% | 0.1% |
| EVO/EVO+ VISIAN Implantable Collamer Lens | 285 | 672 | 0% | 0% |
| EVO/EVO+ VISIAN Implantable Collamer Lens (ICL) | 165 | 405 | 0% | 0% |
| EVO/EVO + VISIAN Implantable Collamer Lens (ICL) | 97 | 317 | 0% | 0% |
| Silicone Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula | 6 | 0 | 0% | 73.6% |
| Collamer Ultraviolet-Absorbing Posterior Chamber Single Piece Foldable Intraocul | 2 | 0 | 0% | 64.3% |
| Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece Foldable Intraocula | 2 | 0 | 0% | 65.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Staar Surgical | 22,009 | 99.6% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Inadequacy of device shape and/or size | 10,647 | 48.2% |
| Off-label use | 2,572 | 11.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 1,184 | 5.4% |
| Explanted | 1,069 | 4.8% |
| Misfocusing | 990 | 4.5% |
| Lens, vaulting | 944 | 4.3% |
| Device dislodged or dislocated | 470 | 2.1% |
| Unintended movement | 441 | 2% |
| Insufficient device problem information | 393 | 1.8% |
| Optical problem | 343 | 1.6% |
| Torn material | 331 | 1.5% |
| Device remains implanted | 246 | 1.1% |
| Other (for use when an appropriate device code cannot be identified) | 214 | 1% |
| Patient-device incompatibilitythe device did not suit the patient | 177 | 0.8% |
| Lens (iol), torn, split, cracked | 112 | 0.5% |
| Breakthe device broke | 88 | 0.4% |
| Malposition of device | 77 | 0.3% |
| Improper or incorrect procedure or method | 75 | 0.3% |
| Positioning failure | 51 | 0.2% |
| Tears, rips, holes in device, device material | 47 | 0.2% |
Questions about lens, intraocular, phakic reports
What is product code MTA?
FDA's classification code for "Lens, intraocular, phakic", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
22,089 reports through August 2026, 821 of them in the latest 12 months.
Which brands appear most often?
Implantable Collamer Lens Icl (13,396), Icl Implantable Collamer Lens (4,477), Visian ICL (Implantable Collamer Lens) (2,314), Implantable Collamer Lens (599) and EVO/EVO+VISIAN Implantable Collamer Lens (419). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.